LTCPA advocates for the interests of the long-term care (LTC) pharmacy community - a community that provides a crucial medications to individuals living in LTC settings. LTCPA provides a national, unified voice on regulatory and market concerns including pharmacy costs, specialized pharmacy services and the Medicare Part D prescription drug benefit.
Together, LTCPA member pharmacies serve 1.7 million Medicare Part D beneficiaries, or ninety percent of all LTC facility residents in the United States.
Independent, Community-Based LTC Pharmacies
LTCPA represents approximately 800 independent LTC, pharmacies located in all 50 states, which are members of the group purchasing organization Managed Health Care Associates (MHA).
Chain-Based LTC Pharmacies
LTCPA represents chain-based LTC pharmacies Omnicare and PharMerica, which together have over 250 pharmacies located in all 50 states.
LTCPA's 2011 study quantifying unused Medicare D drugs in skilled nursing facilities is published in the Sept. 2011 issue of ASCP's peer-reviewed journal, The Consultant Pharmacist.